MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with C

Chlorhexidine + Isopropyl alcohol

Chlorhexidine gluconate 2% / Isopropyl alcohol 70% solution 1.5ml impregnated pads

Unsuitable

Stability notes for Chlorhexidine gluconate 2% / Isopropyl alcohol 70% solution 1.5ml impregnated pads

There are no stability notes for this medicine.

Supplier

Hexi Prep 1.5ml impregnated pads (GAMA Healthcare Ltd)

Chlorhexidine gluconate 2% / Isopropyl alcohol 70% solution 3ml impregnated pads

Unsuitable

Stability notes for Chlorhexidine gluconate 2% / Isopropyl alcohol 70% solution 3ml impregnated pads

There are no stability notes for this medicine.

Supplier

Hexi Prep 3ml impregnated pads (GAMA Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.